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Class switch recombination (CSR) diversifies 
the  humoral  immune  response  by  joining  a 
single antibody variable region gene with differ-
ent constant region (CH) genes responsible for 
unique effector functions (1). This is crucial for 
establishing  immunity,  as  patients  selectively 
deficient in CSR suffer from recurrent and severe 
infections (2). CSR occurs between repetitive 
but  nonhomologous  DNA  sequences  called 
switch (S) regions, which are located upstream 
of each CH gene (except ). CSR requires the 
expression of activation-induced cytidine de-
aminase (AID) (3, 4), an enzyme that is thought 
to directly deaminate single-stranded DNA (5, 6), 
though this mechanism is still under debate (7). 
DNA lesions induced by AID are processed to 
generate double-stranded DNA breaks (DSBs), 
which activate DNA damage response proteins 
to  promote  efficient  long-range  recombination 
(8). DSBs in S and downstream S regions are 
ultimately joined through end joining mecha-
nisms, allowing the expression of a new anti-
body isotype (1).
CSR requires transcription and is targeted 
to individual constant region genes by the selec-
tive activation of isotype-specific intronic (I) 
promoters in response to antigen, cytokine, 
and co-stimulatory signals (9). This “germline 
transcription” begins at I exons and proceeds 
through adjacent S regions and CH genes, giving 
rise to noncoding germline transcripts (GLTs). 
Transcription is thought to initiate CSR by 
promoting S region accessibility and exposing 
single-stranded DNA to AID (1). Indeed, CSR 
is abrogated by I promoter deletions (10, 11) 
and is restored by their replacement with het-
erologous promoters (12, 13). These latter studies 
also demonstrated that constitutively transcribed 
S regions are ectopically targeted for CSR, high-
lighting the role of S region transcription in 
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Class switch recombination (CSR) allows the humoral immune response to exploit different 
effector pathways through specific secondary antibody isotypes. However, the molecular 
mechanisms and factors that control immunoglobulin (Ig) isotype choice for CSR are un-
clear. We report that deficiency for the Ikaros transcription factor results in increased and 
ectopic CSR to IgG2b and IgG2a, and reduced CSR to all other isotypes, regardless of stimu-
lation. Ikaros suppresses active chromatin marks, transcription, and activation-induced 
cytidine deaminase (AID) accessibility at the 2b and 2a genes to inhibit class switching 
to these isotypes. Further, Ikaros directly regulates isotype gene transcription as it directly 
binds the Igh 3 enhancer and interacts with isotype gene promoters. Finally, Ikaros-medi-
ated repression of 2b and 2a transcription promotes switching to other isotype genes by 
allowing them to compete for AID-mediated recombination at the single-cell level. Thus, 
our results reveal transcriptional competition between constant region genes in individual 
cells to be a critical and general mechanism for isotype specification during CSR. We show 
that Ikaros is a master regulator of this competition.
© 2009 Sellars et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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ectopically to IgG2b, IgG2a, and IgG3, produced fewer IgG1
+ 
cells than WT (WT, 30.1 ± 1.63%; IkL/L, 26.2 ± 1.57%), and 
exhibited a 54% reduction in  postswitch transcripts, indicating 
fewer IgE+ cells (Fig. 1 C, Fig. 2 A, and Fig. S1). After LPS + 
IL-5 + TGF- stimulation, WT cells switched to IgG3, IgG2b, 
and IgA, whereas IkL/L cultures generated 2.9-fold more IgG2b
+ 
cells, unexpected IgG2a
+ cells, and fewer IgG3
+ and IgA+ cells 
(32 and 52% of WT, respectively; Fig. 1 D and Fig. S1 D). In 
all of the these conditions, the fraction of switched cells (e.g., 
IgG+ and IgA+) in Ikaros-deficient cultures increased 20–120% 
versus WT, suggesting a general increase in switching capacity 
(Fig. 1). Finally, we confirmed these results by ELISA (Fig. S2), 
demonstrating that isotype expression is significantly skewed   
toward IgG2b and IgG2a in activated Ikaros-deficient B cells.
Because CSR requires proliferation (26) and IkL/L B cells 
hyperproliferate at low stimuli concentrations and cell densi-
ties (21), overall increases in switched cells and/or specific 
increases in IgG2b
+ and IgG2a
+ cells could be caused by in-
creased cell divisions in IkL/L cultures. To evaluate this, CFSE 
dilution was used to track cell division, and the percentage of 
IgG/A+ WT and IkL/L cells in each generation was compared 
for the described conditions. Each generation of IkL/L cells 
exhibited increases in IgG2b
+ and IgG2a
+ cells, as well as increased 
overall switching after all stimulations when compared with 
WT; increases in IgG3
+ cells were also detected after LPS + 
IL-4 stimulation (Fig. S3). Further, IkL/L cells exhibited re-
duced CSR to IgG3 and IgA at every division analyzed and 
to IgG1 after the third division in conditions that induce WT 
cells to switch to these isotypes (LPS, LPS + IFN-, and LPS + 
IL-5 + TGF- for IgG3, LPS + IL-4 for IgG1, and LPS + 
IL-5 + TGF- for IgA; Fig. S3). These results indicate that 
significant, proliferation-independent isotype expression abnor-
malities exist in IkL/L B cells after CSR-inducing stimulation.
It was also possible that the increased IgG2b
+ and IgG2a
+ 
populations in IkL/L cultures could be caused by the expan-
sion of autoreactive cells that had previously switched in vivo, 
rather than specific CSR defects, considering the lower acti-
vation thresholds of IkL/L B cells (21) and the production of 
autoantibodies in transgenic mice expressing a B cell–restricted 
dominant-negative Ikaros isoform (27). Thus, isotype expres-
sion was analyzed using whole and bona fide unswitched B cells 
(B220+, and CD43IgG/A and CD43IgM+, respectively) 
that were stimulated with LPS, LPS + IFN-, and LPS + IL-4. 
Regardless of purification strategy, IkL/L cultures exhibited 
consistent and significant increases in IgG2b
+ and IgG2a
+ (and 
IgG3
+ with LPS + IL-4) cells compared with WT cultures 
(Fig. S4). Further, there were no significant differences in 
IgG2b or IgG2a expression between B220+, CD43IgG/A, 
and CD43IgM+ IkL/L cultures (Fig. S4). Thus, the aberrant 
isotype expression by Ikaros-deficient B cells results from 
defects in CSR and not from the expansion of in vivo–
switched cells.
In summary, IkL/L cells (a) are more likely to undergo CSR, 
(b) display enhanced and ectopic CSR to IgG2b and IgG2a re-
gardless of stimulation, and (c) show reduced CSR to all other 
isotypes (except for ectopic CSR to IgG3 after LPS + IL-4). 
isotype selection. However, the mechanisms establishing this 
targeting are not completely understood, and it is unclear how 
individual cells select between simultaneously transcribed S 
regions for CSR.
Germline transcription is regulated by an enhancer at the 
3 end of the Igh locus and by chromatin modifications. The 
30-kb Igh 3 enhancer lies downstream of C and contains 
four DNase hypersensitive (HS) regions: HS3a, HS1,2, HS3b, 
and HS4. Disruption of the enhancer reduces transcription and 
CSR to all isotypes, with 3, 2b, and 2a most drastically 
affected (14, 15). As the 3 enhancer is distant from I promot-
ers (up to 110 kb), transcriptional control is believed to occur 
through promoter–enhancer looping (16). In addition, histone 
modifications, such as histone H3 acetylation (AcH3) at I exons 
and S regions, are tightly correlated with GLT induction, in-
dicating that they may regulate germline transcription (17, 18). 
Nonetheless, the molecular mechanisms and factors control-
ling S region transcription and isotype specification during 
CSR remain largely undefined.
The Ikaros zinc finger transcription factor plays important 
roles in B cells. Ikaros is required for B cell specification (19, 20) 
and differentiation (20–22), as well as allelic exclusion at the 
Ig locus (23, 24). We have studied Ikaros function in the B cell 
lineage using mice bearing a hypomorphic mutation in the 
ikzf1 (Ikaros) locus (IkL/L). IkL/L mice contain a LacZ reporter 
knocked into ikzf1 exon 2, resulting in the production of low 
levels of functional, but truncated, Ikaros proteins (10%   
of WT) in hematopoietic cells (21). Unlike Ikaros-null mice 
(19), IkL/L mice develop relatively normal numbers of mature, 
polyclonal B cells (21). Interestingly, IkL/L mice exhibit ab-
normal serum antibody titers, characterized by striking >50% 
reductions in IgG3 and IgG1, and >50% increases in IgG2b 
and IgG2a (21). This intriguing observation led us to hypoth-
esize that Ikaros plays a role in isotype selection. In this paper, 
we report that Ikaros is indeed a central regulator of Igh locus 
transcription and isotype specification during CSR.
RESULTS
Ikaros deficiency skews CSR to IgG2b and IgG2a
To determine if Ikaros regulates CSR, switching to all iso-
types was assessed in purified WT and IkL/L splenic B220+  
B cells using a battery of in vitro culture conditions. CSR was 
measured by flow cytometry (FACS) for surface Ig isotype 
expression after 3–4 d in culture. After LPS stimulation, WT 
cells switched only to IgG3 and IgG2b, as expected (Fig. 1 A 
and Fig. S1 A). In contrast, IgG2b
+ cells were 3.6-fold more 
frequent in IkL/L cultures, and IgG2a
+ cells were also detected, 
whereas IgG3
+ cells were reduced (23% of WT; Fig. 1 A and 
Fig. S1 A). After LPS + IFN- stimulation, both genotypes 
switched to the same isotypes, but IkL/L cultures produced 
more IgG2b
+ and IgG2a
+ cells (up 2.3- and 2.7-fold, respec-
tively, vs. WT) and fewer IgG3
+ cells (24% of WT; Fig. 1 B 
and Fig. S1 B). After LPS + IL-4 stimulation, WT cells switched 
to IgG1 (Fig. 1 C and Fig. S1 C) and IgE (as determined by 
RT–quantitative PCR [qPCR] of  postswitch transcripts; 
Fig. 2 A) (25), as expected. In contrast, IkL/L cells switched JEM VOL. 206, May 11, 2009 
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Therefore, Ikaros deficiency results in a B cell–intrinsic defect 
in isotype specification during CSR.
Ikaros function is required during CSR
Because Ikaros is expressed throughout B cell development 
and controls processes such as V(D)J recombination, which 
Figure 1.  CSR is skewed toward IgG2b and IgG2a in IkL/L B cells. CFSE-labeled B220+ WT and IkL/L B cells were stimulated for 72 h with (A) LPS, (B) LPS + 
IFN-, or (C) LPS + IL-4. (D) 24 h with LPS was followed by 72 h with LPS + IL-5 + TGF-. CSR was analyzed by FACS, and percentages of Ig+ cells are  
indicated. The data are representative of more than four independent experiments. Bar graphs represent mean percentages plus SD of switched cells in each 
condition for four (D) or five (A–C) experiments. Significance was determined by a two-tailed t test assuming unequal variance (***, P < 0.005; **, P < 0.02).
may affect the B cell repertoire (19, 20), we asked if Ikaros is 
required in mature B cells during CSR. WT B cells were 
stimulated for 24 h with LPS to induce CSR, and were then 
transduced with retroviruses encoding the dominant-negative 
Ikaros 6 (Ik6) isoform and a truncated human nerve growth 
factor receptor (NGFR) reporter. The Ik6 isoform lacks 1076 IKAROS CONTROLS CSR SPECIFICITY | Sellars et al.
in mutant cells (Fig. S6). Further, multiplex single-cell (SC)–
RT-PCR analysis revealed similar percentages of aicda+ cells 
in both genotypes after LPS (WT, 71%; IkL/L, 67%) and LPS 
+ IL-4 (WT, 65%; IkL/L, 62%) stimulation, suggesting similar 
levels of aicda transcripts per cell (Table S1; see Fig. 9, A and B). 
Thus, higher CSR efficiency in IkL/L cells is not caused by 
increased aicda expression.
Ikaros deficiency results in deregulated  
S region transcription
To determine if Ikaros controls CSR specificity by regulating 
S region transcription, we measured GLT levels for , 3, 
1, 2b, 2a, and  in WT and IkL/L B cells by RT-qPCR. 
Freshly isolated IkL/L cells exhibited three- to sixfold increases 
in 3, 2b, and 2a GLT expression at the population level 
(Fig. 4 A). Further, SC-RT-PCR revealed that 22 and 
6% of IkL/L cells expressed 3 and 2b GLTs, respectively, 
whereas virtually no WT cells expressed either GLT, suggest-
ing that Ikaros represses the transcription of a subset of S re-
gions in the absence of ex vivo stimulation (Fig. S7 and Table 
S1). After 48 h with LPS, LPS + IFN-, or LPS + IL-4, WT 
B cells specifically induced GLTs for the isotypes to which 
they switched (Fig. 1, A–C; and Fig. 4, B–D). IkL/L cells, 
however, expressed markedly different patterns of GLTs, and 
only derepressed GLTs correlated well with CSR. Strikingly, 
2b and 2a GLTs were either overexpressed (>3.5-fold) or 
expressed ectopically (2b with LPS + IL-4, and 2a with 
LPS and LPS + IL-4) in IkL/L cells, and this expression corre-
lated with increased or ectopic CSR to these isotypes (Fig. 1, 
A–C; Fig. 4, B–D; and Fig. S8). Similarly, 3 GLTs were ex-
pressed ectopically with LPS + IL-4 stimulation, which cor-
related with ectopic IgG3 switching (Fig. 1 C and Fig. 4 D). 
In contrast,  GLTs were expressed similarly in both geno-
types, and surprisingly, despite expressing WT levels of 3 
(with LPS and LPS + IFN-), 1 and  GLTs, IkL/L cells 
switched less efficiently to these isotypes (Fig. 1, A–C; Fig. 2; 
and  Fig.  4,  B–D).  Collectively,  these  results  suggest  that 
Ikaros represses the transcription of S3, S2b, and S2a in 
resting and stimulated cells, and that increased germline tran-
scription of S2b and S2a (and S3 after LPS + IL-4) in 
Ikaros-deficient cells skews isotype selection during CSR.
Derepression of S region transcription in IkL/L cells results  
in increased AID-dependent histone modifications
If enhanced S2b and S2a transcription skews switching in 
IkL/L cells, it would be reflected in increased AID accessibility 
and activity in these S regions, as AID-induced DSBs are 
necessary intermediates for CSR (32). To evaluate AID ac-
cessibility, we measured AcH4, which is induced in response 
to DSBs (33, 34) and is up-regulated in an AID-dependent 
manner at S regions during CSR (18). S region AcH4 levels 
were analyzed in both freshly isolated and stimulated (48 h) 
WT  and  IkL/L  cells  by  chromatin  immunoprecipitation 
(ChIP)–qPCR using anti-AcH4 antibodies. S region AcH4 
levels were low in unstimulated B cells of both genotypes,   
as expected (Fig. 5 A). In WT cells, LPS and LPS + IFN- 
DNA binding domain zinc fingers and, upon dimerization, 
inhibits DNA binding by functional Ikaros isoforms (28).   
72 h after infection, switching and NGFR expression were 
analyzed by FACS. WT cells transduced with control virus 
(NGFRhi) switched exclusively to IgG3 and IgG2b, as did un-
infected cells (NGFR) from WT cultures transduced with 
Ik6-NGFR (Fig. 3). Ik6-NGFRhi cells, however, exhibited   
a threefold increase in IgG2b
+ cells, ectopic CSR to IgG2a, 
30–50% fewer IgG3
+ cells, and more switched cells (Fig. 3 
and Fig. S5 A). Thus, inhibiting Ikaros function in mature 
WT B cells during CSR recapitulated the IkL/L switching 
phenotype. Similarly, transduction of IkL/L cells with the full-
length Ik1 isoform rescued IkL/L switching defects (Fig. S5, B 
and C). Importantly, equally effective rescue was achieved 
with the truncated Ik1 isoform that lacks exon 2–derived 
protein sequences and is expressed at low levels in IkL/L cells, 
indicating  that  these  truncated  Ikaros  proteins  function   
like full-length Ikaros during CSR (Fig. S5, B and C) (21). 
Collectively  these  results  show  that  Ikaros  regulates  CSR 
specificity and efficiency in mature B cells.
AID expression is normal in IkL/L B cells
AID protein levels correlate with aicda transcript levels and 
switching efficiency (29–31). Thus, if aicda/AID expression 
were increased in Ikaros-deficient B cells, it could account 
for increased switching. Aicda expression was examined by 
RT-qPCR in WT and IkL/L B cells, either freshly isolated or 
stimulated for 48 h with LPS, LPS + IFN-, or LPS + IL-4. 
Stimulation of WT and IkL/L B cells induced aicda expression 
>48-fold, and there was no significant difference in aicda levels 
between IkL/L and WT, though expression was slightly higher 
Figure 2.  Reduced IgE switching in IkL/L B cells despite normal  
GLT expression. (A) I-C transcript expression in B220+ WT and IkL/L B 
cells after 72 h of stimulation with LPS + IL-4 was analyzed by RT-qPCR. 
The I promoter is equally active in WT and IkL/L cells (Fig. 4, A–D), indicat-
ing that I-C transcripts can be faithfully compared between genotypes 
to quantify IgE-switched cells. (B) RT-qPCR for  GLT expression after 48 h 
of LPS + IL-4 stimulation. Ig was used as a loading control and all values 
were normalized to WT. Significance was determined by a two-tailed t test 
assuming unequal variance (**, P < 0.02). Graphs represent means plus SD 
of two (A) or three (B) independent experiments. Neither I-C transcripts 
nor  GLTs were detected in other conditions (not depicted).JEM VOL. 206, May 11, 2009 
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In IkL/L cells, however, histone H4 was hyperacetylated at 
ectopically and overtranscribed S regions. AcH4 levels were 
consistently higher at S2b and S2a in stimulated IkL/L cells 
compared with WT, correlating with increased transcription 
and switching to these isotypes (Fig. 1, A–C; Fig. 4, B–D; 
and Fig. 5, B–D). Similarly, ectopic AcH4 at S3 in LPS + 
induced H4 acetylation at S3 and S2b, and LPS + IFN- 
also induced AcH4 at S2a; LPS + IL-4 induced AcH4 ex-
clusively at S1 (Fig. 5, B–D). Thus, AcH4 levels mirrored 
GLT and isotype expression in WT cells, confirming that 
AID-dependent chromatin modifications correlate with tran-
scription and switching (Figs. 1, 4, and 5) (18).
Figure 3.  Ikaros regulates CSR in mature B cells. CFSE-stained B220+ WT B cells were activated for 24 h with LPS to induce CSR, infected with  
retroviruses encoding the NGFR reporter alone or with the dominant-negative Ik6 isoform (Ik6-NGFR), and stimulated for another 72 h with LPS. Ig and 
NGFR expression were analyzed by FACS. Numbers represent percentages of NGFR, NGFR+, or IgG+ cells. The data are representative of four independent  
experiments (Fig. S5 A provides a statistical analysis).
Figure 4.  Deregulated expression of 3, 2b, and 2a GLTs in IkL/L B cells. GLTs expressed by B220+ WT and IkL/L B cells that were (A) freshly  
isolated or stimulated for 48 h with (B) LPS, (C) LPS + IFN-, or (D) LPS + IL-4 were analyzed by qPCR. GLTs were normalized to Ig levels and all values 
are represented relative to those of unstimulated WT B cells. Graphs represent means plus SD of three independent experiments. Significance was  
determined by a two-tailed t test assuming unequal variance (***, P < 0.005; **, P < 0.02; *, P < 0.05).1078 IKAROS CONTROLS CSR SPECIFICITY | Sellars et al.
genotypes (Fig. 4 D and Fig. 5 D). Thus, increased transcrip-
tion of S2b and S2a (and S3 after LPS + IL-4) correlates 
with  increased  AID-dependent  H4  acetylation,  suggesting 
that abnormal germline transcription in IkL/L cells increases 
AID accessibility at S2b and S2a (and S3) to skew CSR.
Ikaros does not repress germline transcription by regulating 
promoter–enhancer interactions in the Igh locus
Germline transcription of S3, S2b, and S2a requires the Igh 
3 enhancer (14, 15), and Ikaros has been reported to regulate 
long-range promoter–enhancer looping at the -globin locus 
(35). Therefore, we asked if Ikaros regulates germline tran-
scription by controlling interactions between the 3 enhancer 
and CH gene promoters. Igh locus promoter–enhancer inter-
actions were assayed in WT and IkL/L B cells by chromosome 
conformation capture (3C) to measure interactions between 
distal chromosome regions (36). In these experiments, inter-
acting chromatin was cross-linked with formaldehyde, digested 
with  a  restriction  enzyme,  and  subjected  to  intramolecular 
DNA ligation and qPCR amplification of ligation products 
(Fig. S9 shows digestion and PCR controls). We examined in-
teractions between a HindIII fragment containing the HS1,2 
regulatory site and fragments covering the  enhancer, down-
stream CH gene promoters, HS3a, and HS3b/4, as well as I   
regions not expected to participate in the regulation of germ-
line transcription. Although HS1,2 was chosen as a reference 
point, patterns of promoter–enhancer cross-linking were simi-
lar, though weaker, using a 3 enhancer fragment containing 
HS3b/4 (unpublished data). WT and IkL/L B cells were com-
pared, either before or after 36 h of stimulation, when germ-
line transcription was efficiently induced, but CSR was barely 
detectable by FACS (unpublished data). B cell–specific inter-
actions were identified by comparison with PMA-stimulated 
T cells in which the Igh locus is silent.
In freshly isolated B cells, but not T cells, HS1,2 was fre-
quently cross-linked to a fragment containing the  enhancer, 
as previously reported (Fig. 6 A) (16). This interaction was 
reduced but still present in IkL/L B cells, suggesting that Ikaros 
contributes to –3 enhancer interactions (Fig. 6 A). Cross-
linking between HS1,2 and 3 or 2a in IkL/L B cells was 
similar to WT, despite ectopic 3, 2b, and 2a transcription; 
only HS1,2–2b interactions were increased in mutant cells 
(Fig. 4 A and Fig. 6 A). Thus no clear correlation was detected 
between  CH  promoter–HS1,2  interactions  and  increased 
GLT expression in unstimulated IkL/L cells.
Next, we asked if Ikaros deficiency affects promoter–
  enhancer interactions after stimulation. In LPS-induced 
WT cells, there were B cell–specific HS1,2–3 and –2b 
cross-linking peaks, indicating HS1,2 interactions with these 
CH genes during transcription and switching (Fig. 1 A, Fig. 4 B, 
and Fig. 6 B). In IkL/L cells, HS1,2–2b and –2a cross-linking 
frequencies were similar to WT despite enhanced germline tran-
scription of these genes (Fig. 4 B and Fig. 6 B); HS1,2–3 inter-
actions were also similar between genotypes. After LPS + IFN- 
stimulation, WT cells exhibited significant B cell–specific cross-
linking between HS1,2 and 2a, as well as interaction peaks   
IL-4–stimulated IkL/L cells mirrored ectopic 3 transcription 
and switching (Fig. 1 C, Fig. 4 D, and Fig. 5 D). In contrast, 
normal 3 GLT expression in LPS- and LPS + IFN-–stim-
ulated IkL/L cells induced 25–40% lower AcH4 levels at S3 
in comparison with WT, suggesting reduced AID-dependent 
activity (Fig. 4, B and C; and Fig. 5, B and C). Finally, similar 
1 GLT levels in LPS + IL-4–stimulated IkL/L and WT cells 
resulted in comparable induction of AcH4 at S1 in both 
Figure 5.  AcH4 correlates with transcriptional deregulation in IkL/L 
B cells. WT and IkL/L CD43 B cells that were (A) freshly isolated or stimu-
lated for 48 h with (B) LPS, (C) LPS + IFN-, or (D) LPS + IL-4 were sub-
jected to ChIP with anti-AcH4 antibodies. Graphs represent the mean S 
region AcH4 enrichment indexes plus SD for three to four independent 
experiments. Significance was determined by a two-tailed t test assuming 
unequal variance (***, P < 0.005; **, P < 0.02; *, P < 0.05). AcH4 at S2a 
was consistently higher in IkL/L versus WT samples after LPS + IFN- (S2a 
IkL/L/WT ratio mean = 1.68; range = 1.21–2.13).JEM VOL. 206, May 11, 2009 
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between HS1,2 and 3 and 2b, which correlated with tran-
scription and switching for all three genes (Fig. 1 B, Fig. 4 C, 
and Fig. 6 C). HS1,2–2b and –2a interactions were nearly 
identical in IkL/L cells, despite sharply increased transcription 
and switching mainly to 2a and, to a lesser extent, 2b and 3 
(Fig. 1 B, Fig. 4 C, and Fig. 6 C). On the other hand, HS1,2–3 
interactions were somewhat, but not significantly reduced in 
IkL/L cells (despite normal transcription), indicating a possible 
role for Ikaros in HS1,2–3 interactions after LPS + IFN- 
(Fig. 6 C). Finally, LPS + IL-4 induced consistently higher 
HS1,2–1 interactions in WT and IkL/L B cells versus WT T 
cells, which correlated with transcription and switching at 1 
in response to LPS + IL-4, as previously reported (Fig. 1 C, 
Fig. 4 D, and Fig. 6 D) (16). Importantly, ectopic transcription 
of 3, 2b, and 2a in LPS + IL-4–stimulated IkL/L cells did 
not correlate with modified promoter–enhancer interactions, 
as there were no significant differences between WT and IkL/L 
cells, and only HS1,2–2a cross-linking was slightly increased 
in mutant populations (Fig. 4 D and Fig. 6 D). In summary, 
similar to previous reports, we found interactions between 
HS1,2 and CH genes that were transcribed and targeted for 
CSR in WT cells (16). Further, there was no clear correlation 
between CH promoter–HS1,2 interactions and defects in germ-
line transcription. Therefore, deregulated S region transcrip-
tion and aberrant switching in Ikaros-deficient B cells is not 
caused by altered interactions between the Igh 3 enhancer and 
the promoters of specific CH genes.
Ikaros maintains repressive chromatin at the 2b  
and 2a genes
AcH3 is a hallmark of transcriptionally active chromatin (37) 
and correlates tightly with germline transcription (17, 18). 
Thus, we asked if Ikaros could regulate S region transcription 
by controlling H3 acetylation. AcH3 was examined at C I 
exons and S regions in WT and IkL/L B cells by ChIP-qPCR, 
both before and after 48 h of stimulation. There were no sig-
nificant differences in AcH3 levels between freshly isolated 
WT and IkL/L cells (Fig. 7 A). This suggests that AcH3 levels 
either do not contribute to GLT overexpression, or that our 
assay lacked the sensitivity required to detect differences in 
AcH3 associated with low levels of transcription (Fig. 4 A).
Next, we determined if AcH3 levels correlate with dereg-
ulated germline transcription in IkL/L B cells after stimulation. 
Stimulated WT cells induced H3 acetylation at the isotype 
genes they transcribed: I/S3 and I/S2b with LPS and LPS + 
IFN-, I/S2a with LPS + IFN-, and I/S1 with LPS + 
IL-4 (Fig. 4, B–D; and Fig. 7, B–D). Strikingly, in stimulated 
IkL/L cells, AcH3 levels at the 2b and 2a I exons and/or S 
regions were consistently higher than in WT cells, and corre-
lated with increased and ectopic transcription (Fig. 4, B–D; 
and Fig. 7, B–D). Similarly, ectopic AcH3 at I/S3 in LPS + 
IL-4–stimulated IkL/L cells correlated with ectopic transcription 
of that isotype (Fig. 4 D and Fig. 7 D). Normal levels of 3 
(LPS and LPS + IFN-) and 1 (LPS + IL-4) transcription in 
IkL/L cells were associated with AcH3 levels at I/S3 and I/S1 
that were equivalent to WT (Fig. 4, B–D; and Fig. 7, B–D). 
Importantly, AcH3 enrichment at the 3 enhancer was also 
similar between WT and IkL/L cells (unpublished data). Thus, 
deregulated transcription and AcH3 are tightly correlated in 
Figure 6.  Ikaros does not regulate interactions between HS1,2  
and CH gene promoters. CD43 WT and IkL/L B cells were analyzed by 3C, 
either (A) before or after 36 h with (B) LPS, (C) LPS + IFN-, or (D) LPS + IL-4. 
CD4+ T cells stimulated for 36 h with PMA served as a negative control. 
The y axis represents the relative cross-linking frequency between a HindIII 
fragment covering HS1,2 and the rest of the locus. Points represent means 
plus SD of two independent experiments. Significance was determined by 
a two-tailed t test assuming unequal variance (***, P < 0.005; **, P < 0.02; 
*, P < 0.05). In A, HS1,2–HS3a and –HS3b/4 cross-linking frequencies in  
B cells, though similar between genotypes, were too high to be shown.1080 IKAROS CONTROLS CSR SPECIFICITY | Sellars et al.
induced transcription at I3, I2b, and I2a, indicating that 
Ikaros associates strongly with some I exons upon their tran-
scriptional activation (Fig. 8 C). Similarly, after LPS + IL-4 
stimulation, Ikaros associated with the transcribed I1 exon 
(Fig. 4 D and Fig. 8 D). In addition, there was moderate 
Ikaros association with I2b, whereas the HS1,2 peak remained 
high (Fig. 8 D). Thus, Ikaros strongly associates with HS1,2 
regardless of stimulation, with I2b in all conditions but most 
strongly when I2b is normally transcribed in WT, and with 
I3, I1, and I2a when they are transcriptionally induced 
upon stimulation.
To determine if Ikaros binds directly to any of these se-
quences, we performed EMSA. Exogenous Ikaros, confirmed 
by supershift, bound strongly to a probe containing a putative 
Ikaros binding site from HS1,2 (Fig. 8 E). Interestingly, endoge-
nous Ikaros complexes also bound this probe, indicating that 
Ikaros can directly bind HS1,2 (Fig. 8 F). In contrast, Ikaros 
did not bind to putative sites from I2b or I2a, and super-
shift with Ikaros-specific antibodies revealed only low affinity 
binding to sites in I1, in keeping with a previous report 
IkL/L cells, indicating that Ikaros promotes a repressive chro-
matin state (e.g., histone H3 hypoacetylation) at CH promot-
ers and genes during CSR.
Ikaros interacts directly with the Igh locus
We next asked if Ikaros could control chromatin remodeling 
and S region transcription through direct binding to Igh regu-
latory regions. We analyzed Ikaros binding to the Igh locus   
in freshly isolated and stimulated WT B cells by ChIP-qPCR 
using anti-Ikaros antibodies. We focused on regions in the Igh 
3 enhancer and C gene promoters, I exons and S regions, 
that contained Ikaros consensus sites identified with the TF-
SEARCH algorithm (38).
Ikaros associated with the Igh locus in vivo in WT B cells 
(Fig. 8). In freshly isolated CD43 cells, Ikaros associated 
with I2b and HS1,2 in the 3 enhancer (Fig. 8 A). These 
associations were maintained after LPS stimulation (Fig. 8 B). 
When cells were stimulated with LPS + IFN-, Ikaros asso-
ciated at low levels with I3 and at higher levels with I2b, 
I2a, and HS1,2 (Fig. 8 C). Interestingly, this stimulation also 
Figure 7.  Increased AcH3 at 3, 2b, and 2a in IkL/L B cells. WT and IkL/L CD43 B cells that were (A) freshly isolated or stimulated for 48 h with 
(B) LPS, (C) LPS + IFN-, or (D) LPS + IL-4 were subjected to ChIP with anti-AcH3 antibodies. Graphs represent the mean I exon (I) and S region (S) AcH3 
enrichment indexes plus SD for three independent experiments. Significance was determined by a two-tailed t test assuming unequal variance (***, P < 
0.005; **, P < 0.02; *, P < 0.05). S2b and S2a AcH3 levels were consistently higher in IkL/L versus WT samples after LPS + IFN- (S2b IkL/L/WT ratio  
mean = 2.68 [range = 1.82–3.47]; S2a IkL/L/WT ratio mean = 2.41 [range = 1.45–3.87]).JEM VOL. 206, May 11, 2009 
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Figure 8.  Ikaros associates with CH promoters and HS1,2 of the 3 enhancer. WT CD43 B cells that were (A) freshly isolated or stimulated  
for 48 h with (B) LPS, (C) LPS + IFN-, or (D) LPS + IL-4 were subjected to ChIP-qPCR with anti-Ikaros antibodies. Points represent mean Ikaros enrich-
ment, measured as percentage input, plus SD from two to three independent experiments. Approximate amplicon positions relative to transcription 
start sites or the 5 ends of HS sites are indicated. Dashed lines represent the mean percentage input for each condition and are defined as the thresh-
old of specific Ikaros binding. (E and F) EMSAs were performed on putative Ikaros binding sites from sequences identified by ChIP (A–D). (E) Nuclear 
extracts from Cos cells transduced with an empty vector (V) or one encoding the Ik1 isoform (Ik) were incubated with the indicated probes (Table S2). 
Two putative I1 Ikaros binding sites were tested. (F) The HS1,2 probe was incubated with nuclear extracts from WT or IkL/L B cells stimulated for 36 h 
with LPS (L), LPS + IL-4 (4), or LPS + IFN- (I). Specificity was verified by supershift with anti-Ikaros antibodies. Arrowheads indicate Ikaros complexes.  
Data in E and F are representative of two independent experiments.1082 IKAROS CONTROLS CSR SPECIFICITY | Sellars et al.
was associated with strongly skewed CSR to IgG2b (Fig. 1 A). 
To explain this difference, we examined per cell transcript lev-
els and found that 2b GLTs were expressed at 8.5 times higher 
levels per 2b+ cell in IkL/L versus WT cultures, whereas 3 
GLT levels were similar on a per cell basis (up 1.6-fold in IkL/L 
vs. WT; Fig. 9 D). Thus, although both WT and IkL/L B cells 
cotranscribe S3/S2b, increased S2b transcription in IkL/L 
cells coincides with IgG2b-skewed switching, indicating that 
higher S2b transcription outcompetes S3 transcription for 
AID-mediated CSR.
Similarly increased competition was found after LPS + IL-4 
stimulation. 91.0% of aicda+ IkL/L cells expressed 3 (57.2%, up 
22.9%) and/or 2b (83.8%, up 50.8%) GLTs, indicating that 
these S regions directly compete with S1 for CSR in most 
cells (Fig. 9, B and C). In addition, LPS + IL-4–stimulated 
IkL/L cells expressed 3 and 2b GLTs at per cell levels that 
were three- to fourfold higher than those found in similarly 
stimulated WT cells, and nearly equivalent to those observed 
in LPS-stimulated WT cells (Fig. 9 D). This correlated with 
ectopic CSR to these isotypes and reduced CSR to IgG1 
(Fig. 1 C). Thus, in LPS + IL-4–stimulated IkL/L cells, high 
levels of S2b/S3 transcription successfully compete with 
transcription of S1 for CSR.
Collectively, these observations demonstrate that the major-
ity of B cells cotranscribe S regions, and that per cell transcrip-
tion rates correlate with isotype selection. Further, our results 
strongly support the hypothesis that increased transcription of 
S2b and S2a (and S3 with LPS + IL-4) in IkL/L cells out-
competes transcription of other S regions for CSR and thus 
skews isotype selection.
DISCUSSION
In this study, we identify Ikaros as a critical regulator of Ig iso-
type selection in B cells during CSR. Ikaros deficiency results 
in increased and ectopic switching to IgG2b and IgG2a (and 
ectopic switching to IgG3 with LPS + IL-4) and enhanced 
overall switching, but reduced switching to IgG3 (with LPS 
and LPS + IFN-), IgG1, IgE, and IgA. This function is inde-
pendent of Ikaros’s role in B cell development, as inhibition 
of Ikaros in mature WT cells skews isotype selection to IgG2b 
and IgG2a, whereas retroviral expression of Ikaros in IkL/L  
B cells rescues CSR. Further, in direct correlation with their 
CSR phenotype, IkL/L cells exhibit sharp increases in tran-
scription and AcH4, an AID-dependent histone mark, at S2b 
and S2a (and S3 with LPS + IL-4) but not other S regions. 
Ikaros directly binds the Igh locus in vivo and is required to 
prevent hyperacetylation of histone H3 at the 2b and 2a 
(and 3 with LPS + IL-4) genes upon B cell activation. Thus, 
Ikaros maintains repressive chromatin at 2b and 2a (and 3 
with LPS + IL-4), and suppresses transcription, AID accessi-
bility, and switching to these isotypes. These results identify 
Ikaros as the first factor that controls the range of isotypes   
targeted by CSR.
Our results also reveal that the choice to undergo CSR to 
specific CH genes is controlled by the balance of germline 
transcription across different S regions within individual cells. 
(Fig. 8 E) (39). Collectively, these results indicate that Ikaros 
regulates germline transcription by binding directly to HS1,2, 
but suggest that its association with I regions is indirect, 
possibly through enhancer–promoter interactions.
Ikaros controls transcriptional competition  
between S regions
The data described in the previous sections demonstrate that 
increased and ectopic transcription of 2b and 2a (and 3 
with LPS + IL-4) in IkL/L cells correlates with enhanced/ectopic 
switching to these isotypes. Paradoxically, CSR to IgG3, IgG1, 
and IgE is decreased in IkL/L cells despite normal GLT levels 
(Figs. 1, 2, and 4). We hypothesized that this discrepancy was 
caused by increased/ectopic transcription of S2b/S2a (and 
S3) outcompeting transcription of other S regions for AID-
mediated CSR. This model would require that (a) S regions 
are cotranscribed in individual cells and (b) transcription of 
S2b/S2a (and S3 with LPS + IL-4) is selectively increased 
relative to that of other S regions. To test this hypothesis, we 
examined the expression of aicda, and 3 and 2b GLTs (and 
actb as a positive control) by SC-RT-PCR in LPS- and LPS 
+ IL-4–stimulated (48 h) IgM+ cells (Fig. 9 and Table S1). 
Importantly, because interallelic CSR occurs efficiently in WT 
cells (40, 41), SC-RT-PCR was performed without regard 
for allele. In LPS-stimulated WT cells, 97.1% of switching 
competent cells (e.g., aicda+) expressed GLTs for 2b (90.1%) 
and/or 3 (78.5%), which correlated with switching to these 
two isotypes (Fig. 1 A; and Fig. 9, B and C). Interestingly, 
91.7% of 3 GLT+ cells also transcribed 2b, whereas 15–20% 
of WT cells switched to IgG3 after 4 d, indicating that the 
majority of WT cells cotranscribe S regions and that cells cotran-
scribing 2b and 3 can still choose 3 for CSR (Fig. 3 and 
Fig. 9 C). In LPS + IL-4–stimulated cells, the high efficiency 
of IgG1 switching suggests that 1 GLTs are expressed in almost 
all cells (Fig. 1 C); 1 PCRs were not performed because of 
the added complexity of performing a fifth PCR in multi-
plex. Interestingly, 53.9% of aicda+ WT cells expressed GLTs 
for 3 (34.3%) and/or 2b (29.8%), suggesting competition 
with S1 in a subset of WT cells (Fig. 9, B and C). However, 
by combining SC-RT-PCR and RT-qPCR data (Fig. 4, B 
and D), we calculated that the levels of S3 and S2b tran-
scripts per 2b+/3+ cell were four times lower in LPS + IL-
4–stimulated WT cells than in cells stimulated with LPS (Fig. 
9 D). These low levels appear insufficient to induce CSR to 
2b and 2a (Fig. 1 C). Thus, S regions are cotranscribed in 
WT cells and relative S region transcription rates per cell corre-
late with CSR, indicating that S region competition can occur 
under normal conditions and may regulate isotype choice.
S region competition is increased in Ikaros-deficient   
B cells. After LPS stimulation, virtually every aicda+ IkL/L cell 
expressed 2b GLTs (99.1% 2b GLT+ cells), whereas the 
frequency of cells expressing 3 GLTs was slightly lower than 
in WT (64.3% of IkL/L cells, down 14%; Fig. 9 A). Strikingly, 
every 3 GLT+ IkL/L cell also expressed 2b GLTs, putting 
S3 in constant competition with S2b (Fig. 9 C). Unlike in 
WT cells, however, S3/S2b cotranscription in IkL/L cells JEM VOL. 206, May 11, 2009 
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scription by Ikaros is required to maintain a balance between 
S2b and S3 transcription, allowing for normal switching   
to both isotypes. Similarly, Ikaros fine tunes S2b and S2a 
transcription in response to LPS + IFN-, to allow switch-
ing to IgG3. Therefore, in addition to suppressing promiscu-
ous switching to IgG3/2b/2a in response to LPS + IL-4, and 
We have shown that the majority of aicda+ LPS-stimulated WT 
cells coexpress GLTs for 2b and 3, suggesting competition 
between these two isotypes for switching. Further, selective 
increases in 2b GLTs in IkL/L cells, where 3 is always co-
transcribed with 2b, correlate with increased CSR to IgG2b 
and decreased CSR to IgG3. Thus, repression of S2b tran-
Figure 9.  Increased S region competition at the SC level for CSR in IkL/L B cells. SC-RT-PCR was performed on IgM+ WT and IkL/L cells after  
48 h of stimulation and two divisions (assessed by CFSE dilution). (A and B) Representative data from cohorts of (A) LPS- and (B) LPS + IL-4–stimulated 
cells are shown. Only actb+ wells were counted (positive control for sorting). Bar graphs represent mean percentages plus SD of cells positive for Aicda, 
or 3 or 2b GLTs, from two independent experiments (0, no cells; 1, one cell; raw data are shown in Table S1). (C) Pie charts represent mean percentages 
of aicda+ cells expressing GLTs for 3, 2b, both, or neither. The numbers of aicda+ cells analyzed over two experiments are indicated (chart centers). 
(D) Data from C was integrated with GLT expression levels measured by RT-qPCR (Fig. 4, B and D) to give a comprehensive view of 2b and 3 GLT 
expression in individual cells. Pie chart wedges represent the percentages of aicda+ B cells that express the indicated GLTs. Wedge radii are defined 
such that the wedge area corresponds to total GLT expression levels; 3 and 2b GLT levels were normalized to LPS-stimulated WT B cells, for which 
the radius was set to 1. Thus, the percentage of degrees out of 360 taken by each wedge corresponds to the percentage of expressing cells, and the  
wedge area corresponds to the integrated per cell expression level.1084 IKAROS CONTROLS CSR SPECIFICITY | Sellars et al.
affects transcription of and CSR to 3, 2b, and 2a, the CH 
genes most strongly affected by Ikaros deficiency (14, 15). One 
issue with this model is that HS1,2 deletion does not affect 
CSR (14), suggesting that HS1,2 may be not be functionally 
important for CSR and/or that it functions independently of 
Ikaros. This explanation, however, is probably too simplistic. 
In another complex locus, the -globin locus, deletions of in-
dividual regulatory elements result in little to no phenotype, 
whereas combined deletions can drastically inhibit globin gene 
expression, indicating that the loss of individual elements can 
be compensated for by redundant functions in other regions 
(49). Thus, compensation by other 3 enhancer elements, 
which have many similar transcription factor motifs (50), could 
explain the lack of CSR phenotype in HS1,2/ cells. In addi-
tion, HS1,2 can strongly synergize with other HS fragments to 
activate transcription (51), and the core region HS1,2 is highly 
conserved between mouse, rat, rabbit, and human (52), indi-
cating that HS1,2 is likely to play important roles in CSR.
How then, can HS1,2/ and IkL/L B cell CSR phenotypes 
be reconciled? An obvious possibility is that Ikaros could repress 
germline transcription and histone acetylation by antagoniz-
ing positive regulatory functions at this element. In this case, 
HS1,2 deletion would abolish both negative regulation by 
Ikaros and positive regulation by unknown factors, resulting 
in a neutral phenotype. In contrast, Ikaros deficiency would 
allow increased activity by positively acting factors, resulting in 
a significant phenotype. Interestingly, Ikaros has been shown 
to compete with positive regulators to modulate the transcrip-
tion of target genes in other settings (22, 53, 54). In this respect, 
our EMSA assay indicates that multiple factors can bind at or 
near the HS1,2–Ikaros binding site (Fig. 8 F). Thus, it will be 
important to determine if Ikaros competes with other factors 
for binding to the HS1,2 regulatory element to fine tune germ-
line transcription.
Finally, the efficiency of CSR is controlled by several mech-
anisms, including cell proliferation, AID expression, subcellular 
localization and posttranslational modifications, DSB forma-
tion, DNA repair, S region synapsis, and end joining (1). Our 
results suggest that S region transcription rates in WT cells also 
limit switching efficiency. This concept is supported by (a) the 
low rates of CSR compared with switching competency in 
WT cells (30% of cells switched after 4 d with LPS, whereas 
70% were aicda+GLT+ after 48 h; Fig. 3, Fig. 9A, and Table 
S1), (b) the similar levels of CSR-competent cells in IkL/L and 
WT cultures (67% of IkL/L cells were aicda+GLT+ after 48 h; 
Fig. 9 A and Table S1), and (c) the direct correlation between 
increased per cell GLT levels, AID accessibility, and switching 
frequency in IkL/L cells (50% switched after 4 d; Fig. 5 B, 
Fig. 9 D, and Fig. S5 B). Why it would be advantageous to 
limit S region transcription rates and CSR efficiency under 
normal conditions is not clear. This mechanism could result in 
more flexible humoral immune responses in vivo, as slowing 
the rate of CSR may prevent B cells from switching en masse 
soon after activation, thus allowing isotype selection to be modi-
fied over time. In addition, reduced S region transcription, and 
therefore DSB formation, would decrease the probability of 
IgG2a in response to LPS, Ikaros limits transcription across 
S2b and S2a so that germline transcription of other S regions 
(i.e., S3 and S) can effectively compete for switching. These 
results indicate that the isotype fate of individual cells during 
CSR is determined by the relative levels of germline transcrip-
tion across different S regions. Considering that single human 
B cells have also been reported to transcribe multiple S regions 
simultaneously (42), this is likely a general mechanism, across 
species, for isotype selection during CSR.
A question arising from our work is how Ikaros suppresses 
transcription at 3, 2b, and 2a. Interestingly, we have found 
that histone H3 is hyperacetylated at these genes in IkL/L cells. 
Although it is possible that these increased AcH3 levels result 
from transcription-coupled processes, it is attractive to specu-
late that Ikaros regulates germline transcription by maintain-
ing a repressive chromatin structure. In this respect, it is well 
documented that histone acetylation contributes to transcrip-
tion by opening chromatin and/or providing binding plat-
forms for regulatory factors (43, 44).
Considering that H3 is hyperacetylated in IkL/L cells and 
that Ikaros interacts with the Sin3 and NuRD histone deacet-
ylase (HDAC) complexes (45–48), we expected Ikaros to re-
cruit these complexes to the Igh locus to regulate germline 
transcription. However, we have been unable to find reduced 
Igh locus occupancy for Sin3a, Mi-2 (a core member of 
NuRD), HDAC1, or HDAC2 in IkL/L versus WT cells by 
ChIP-qPCR or double cross-linking (DC)–ChIP-qPCR (Fig. 
S10). Furthermore, shRNA knockdown of Mi-2 in WT B 
cells neither increased 2b transcription nor altered switching 
specificity (Fig. S11). These data indicate that Ikaros does not 
suppress H3 acetylation and germline transcription by recruit-
ing the NuRD and Sin3 HDAC complexes to the Igh locus.
Our  results  indicate  that  Ikaros  may  directly  regulate 
germline transcription through the HS1,2 region of the Igh 3 
enhancer. Ikaros associates with HS1,2 in all conditions tested, 
and Ikaros proteins bind directly to a sequence in this region 
in vitro. In contrast, despite the association of Ikaros with the 
I1, I2b, and I2a regions by ChIP, we were unable to 
identify sequences in these regions that could be strongly and 
directly bound by Ikaros. Although we cannot rule out bind-
ing to noncanonical sites, these data suggest that Ikaros binds 
directly to HS1,2 and interacts indirectly with I1, I2b, and 
I2a. Our 3C data, as well as those from Wuerffel et al. (16), 
support this interpretation, as HS1,2 interacts with fragments 
containing the 3, 1, 2b, and 2a I promoters/exons. Inter-
estingly, HS1,2–1 interactions increase when this gene is tran-
scribed (e.g., LPS + IL-4; Figs. 4 and 6) (16), which correlates 
with the appearance of an Ikaros binding peak by ChIP. Simi-
larly, Ikaros associates with I2a only when cells are stimulated 
with LPS + IFN-, which induces both 2a GLTs and increased 
HS1,2-I2a interactions. Thus, we propose that Ikaros inter-
acts indirectly with and regulates CH gene promoters through 
HS1,2.
The  idea  that  Ikaros  mediates  repression  through  the 
HS1,2 regulatory region of the 3 enhancer is bolstered by 
the observation that 3 enhancer disruption most drastically JEM VOL. 206, May 11, 2009 
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(mock) vectors were previously described (57). Vectors were transfected into 
Eco-Phoenix packaging cells (provided by G. Nolan, Stanford University, 
Stanford, CA) to produce high-titer retroviral supernatants. 3.5 × 105 CFSE-
stained cells (1.2 × 106 cells/ml) were cultured in LPS for 24 h, transduced 
with retroviral supernatant (25% total vol; 4 µg/ml polybrene; 25 µg/ml 
LPS), and centrifuged for 90 min at 2,600 rpm. Medium was replaced after 
12 h and cells were analyzed 60 h later.
ChIP. The ChIP protocol was adapted from Wang et al. (18) and Millipore 
(http://www.millipore.com/techpublications/tech1/mcproto407). In brief, 
1.8 × 107 B cells were cross-linked at 37°C for 10 min in 5 ml PBS/0.5% 
BSA/1% ultra-pure formaldehyde (Electron Microscopy Sciences). After 
quenching with 0.125 M glycine and a cold PBS wash (with 1× protease   
inhibitor cocktail [PIC]; Roche), cells were lysed in 5 ml of Triton X lysis 
buffer for 10 min on ice (1% Triton X-100, 50 mM MgCl2, 100 mM Tris-
HCl [pH 7.1], 11% sucrose, 1× PIC). Nuclei were pelleted at 2,000 rpm for 
10 min (4°C) and were lysed in 500 µl of SDS lysis buffer for 10 min on ice 
(1% SDS, 50 mM Tris-HCl, 10 mM EDTA, 1× PIC). Chromatin was soni-
cated to 500-1,000 bp using a Bioruptor 200 (Diagenode), and sonication 
efficiency was checked. After 2× dilution in ChIP buffer (0.01% SDS, 1.1% 
Triton X-100, 1.2 mM EDTA, 16.7 mM Tris-HCl [pH 8.1], 167 mM 
NaCl), chromatin was precleared by rotating for 2 h at 4°C with 80 µl 50% 
protein A slurry (0.2 mg/ml sheared salmon sperm DNA, 0.5 mg/ml BSA, 
50% protein A; GE Healthcare). 1.3 × 106 cell equivalents were saved as in-
put. 3.9 × 106 cell equivalents were incubated overnight with 2 µg anti-
AcH3 (Millipore), 2 µg anti-AcH4 (Millipore), 2.5 µg anti-Ikaros (rabbit 
anti–mouse produced in house), anti–Mi-2 (5 µl of rabbit serum; gifts from 
P. Wade [National Institute of Environmental Health Sciences, Research 
Triangle Park, NC] and S. Smale), 5 µg anti-Sin3a (Santa Cruz Biotechnol-
ogy, Inc.), 5 µg anti-HDAC1 (Abcam), 5 µg anti-HDAC2 (Abcam), and 
control antibodies (Bethyl Laboratories). ChIPs were recovered with 65 µl 
50% protein A slurry for 5 h and processed according to the Millipore pro-
tocol. ChIP and input DNA was dissolved in 140 µl TE buffer (10 mM 
Tris-HCl, 1 mM EDTA [ph 8]), and inputs were diluted 10 times. 2-µl ali-
quots were analyzed (in duplicate) by qPCR. Calculations were as follows: 
percentage input (%I) = 100 × ([antibody bound]  [IgG bound])/(input*10); 
and histone acetylation index = (%IIgh sequence)/(%IHprt promoter). For DC-ChIP, 
cells were first fixed with disuccinimidyl glutarate (58).
3C. 3C was performed as previously described (59) with some modifica-
tions. In brief, 11 × 106 cells were fixed for 10 min in 10 ml 1× PBS/0.5% 
BSA/1.5% formaldehyde (Electron Microscopy Sciences) at room tempera-
ture with tumbling (10 rpm). Fixation was quenched with 0.125 M glycine. 
Cells were washed one time in cold PBS/1× PIC and lysed for 10 min on 
ice in 1 ml of lysis buffer (10 mM Tris [pH 8], 10 mM NaCl, 0.2% NP-40, 
1× PIC). After centrifugation, cells were resuspended in 537 µl of digestion 
buffer (60 µl of 10× buffer R [Fermentas], 1× PIC). SDS was added to 0.3% 
and samples were rotated for 1 h at 37°C (99 rpm). Triton X was added to 
1.8% to sequester SDS, bringing the total volume to 600 µl. Samples were 
rotated (99 rpm) for 1 h at 37°C before overnight digestion with 500 U 
HindIII (50 rpm; New England Biolabs, Inc.). HindIII was inactivated by 
adding SDS to 1.75% and incubating for 20 min at 65°C. 106 cell equivalents 
were removed, de–cross-linked, and analyzed by qPCR to monitor diges-
tion efficiency (routinely 80–90%; Fig. S9 A). 107 cell equivalents were di-
luted to 8 ml in 1× ligation buffer (New England Biolabs), 1% Triton X, and 
1× PIC, and SDS was sequestered by rocking for 1 h at 37°C. 4,000 NEB 
U of ligase (New England Biolabs, Inc.) were added and samples were 
rocked for 10 min at 4°C before incubation for 6 h at 16°C, followed by 30 
min at room temperature. Samples were de–cross-linked overnight at 65°C 
with 300 µg protease K and were retreated with 300 µg protease K for 1 h at 
45°C.  DNA  was  extracted  using  ultra-pure  phenol/chloroform/isoamyl   
alcohol (25:24:1; Invitrogen), washed two times with chloroform, ethanol 
precipitated with 2.5 M ammonium acetate, and washed four times with 
75% ethanol. After suspension in TE, relative DNA concentrations were 
calculated by qPCR (ChIP primers “HS4 0.5 kb”).
unrepaired DSBs, which can to lead to oncogenic transloca-
tions (55).
In summary, our results reveal transcriptional competition 
between constant region genes as a central and general mech-
anism for isotype specification during CSR. We have shown 
that Ikaros is a master regulator of this competition.
MATERIALS AND METHODS
Mice. The IkL/L mouse line was previously described (21). Mice back-
crossed >10 times onto the C57BL/6 genetic background were analyzed 
at 5–9 wk of age. All animal work was performed under protocols approved 
by the Direction des Services Vétérinaires du Bas-Rhin, France (authorization 
no. 67-343).
Cell  culture.  Spleen  cells  were  used  for  all  experiments.  B  cells  (B220+, 
IgM+CD43, or CD43IgG/A cells; >98% purity) were sorted on a 
FACSVantage SE option DIVA (BD) or enriched by depletion of CD43+ cells 
with MACS beads (>90% purity), and CD4+ T cells were isolated with anti-
CD4 MACS beads (>90% purity; Miltenyi Biotech). Cells were labeled with 5 
µg/ml CFSE (10 min at 37°C; Sigma-Aldrich) and were maintained at 1.2 × 106 
cells/ml in complete medium (RPMI 1640, 10% FCS, 25 mM Hepes, 1 
mM sodium pyruvate, 2 mM l-glutamine, 1× nonessential amino acids, 5 × 
105 M 2-mercaptoethanol, and 1% antibiotics) with 25 µg/ml LPS (serotype 
0111:B4 from Escherichia coli; Sigma-Aldrich), 5 ng/ml IL-4 (Sigma-Aldrich), 
100 ng/ml IFN- (PeproTech), 3 ng/ml TGF- (R&D Systems), 5 ng/ml 
IL-5 (BD), and 0.5 ng/ml PMA (Sigma-Aldrich).
Flow cytometry. Reagents included anti-B220–FITC (RA3-6B2), anti–
mouse IgG2b–biotin (RMG2b-1; BioLegend), anti–mouse IgA–PE (Southern-
Biotech), F(ab)2 goat anti–mouse IgM–Cy5 and streptavidin-Cy5 or -PE 
(Jackson ImmunoResearch Laboratories), anti–mouse IgG3–biotin (R40-82), 
anti–mouse IgG1–biotin (A85-1), anti–mouse IgG2a
b–biotin (Igh-b; 5.7) and 
anti-CD43–PE  (BD),  goat  anti–mouse  IgG  (H+L)–biotin  (Invitrogen), 
anti-NGFR–Cy5 (8737; provided by W. Pear, University of Pennsylvania, 
Philadelphia, PA), and 7-aminoactinomycin D (Sigma-Aldrich). Cells were 
analyzed with a FACSCalibur (BD) and FlowJo software (Tree Star, Inc.).
RT-qPCR. RNA was isolated with RNeasy kits (QIAGEN). 350 ng RNA 
was reverse transcribed in 20 µl (50 mM Tris-HCl [pH 8.3], 75 mM KCl, 3 
mM MgCl2, 10 mM dithiothreitol, 500 µM dNTP, 10 U recombinant 
RNasin ribonuclease inhibitor [Promega], 0.5 µM oligo d(T) [New England 
Biolabs, Inc.], and 40 U SuperScript II RT [Invitrogen]). SYBR Green 
JumpStart Taq ReadyMix (Sigma-Aldrich) was used for all qPCRs. Approxi-
mately 3 ng of cDNA was run (in triplicate) on a LightCycler 480 (96-well 
plate format) and analyzed with LightCycler 480 basic software (Roche). 
Transcript quantities for each gene were calculated relative to standard curves 
and normalized to Ig transcripts. Gene of interest/Ig ratios for each condi-
tion were averaged across experiments and normalized to the indicated WT 
condition, to give relative expression versus WT or versus unstimulated WT, 
as noted. Table S2 lists oligonucleotides for all experiments.
SC-RT-PCR. Two rounds of PCR were performed with fully nested primers, 
as previously described (54). Only actb+ wells were analyzed (>90%).
Retrovirus production and transduction. MigR1-NGFR (provided by   
W. Pear) is an murine stem cell virus–based retrovirus (56). Ik1 cDNA was 
amplified from mouse spleen cDNA by PCR (bp 271–1,818; available from 
GenBank/EMBL/DDBJ under accession no. NM_001025597). Ik1* cDNA 
was  obtained  by  site-directed  mutagenesis  to  delete  exon  2–derived  Ik1 
  sequences (bp 310–430). Ik6 cDNA was obtained by fusing PCR fragments 
for exons 1 and 2 (bp 271–429) and exon 7 (bp 1,117–1,818) of Ik1. cDNAs 
were cloned into the MigR1-NGFR vector and were designated Ik1-NGFR, 
Ik1*-NGFR, and Ik6-NGFR. pQsupR-Mi2 (Mi-2 shRNA; provided by 
S. Smale, University of California, Los Angeles, Los Angeles, CA) and pQsupR 1086 IKAROS CONTROLS CSR SPECIFICITY | Sellars et al.
  5.  Petersen-Mahrt, S.K., R.S. Harris, and M.S. Neuberger. 2002. AID 
mutates E. coli suggesting a DNA deamination mechanism for antibody 
diversification. Nature. 418:99–103. 
  6.  Rada, C., G.T. Williams, H. Nilsen, D.E. Barnes, T. Lindahl, and M.S. 
Neuberger. 2002. Immunoglobulin isotype switching is inhibited and 
somatic hypermutation perturbed in UNG-deficient mice. Curr. Biol. 
12:1748–1755. 
  7.  Muramatsu, M., H. Nagaoka, R. Shinkura, N.A. Begum, and T. Honjo. 
2007. Discovery of activation-induced cytidine deaminase, the engraver 
of antibody memory. Adv. Immunol. 94:1–36. 
  8.  Ramiro, A., B.R. San-Martin, K. McBride, M. Jankovic, V. Barreto, 
A. Nussenzweig, and M.C. Nussenzweig. 2007. The role of activation-
induced deaminase in antibody diversification and chromosome translo-
cations. Adv. Immunol. 94:75–107. 
  9.  Chaudhuri, J., and F.W. Alt. 2004. Class-switch recombination: interplay 
of transcription, DNA deamination and DNA repair. Nat. Rev. Immunol. 
4:541–552. 
  10.  Jung, S., K. Rajewsky, and A. Radbruch. 1993. Shutdown of class 
switch recombination by deletion of a switch region control element. 
Science. 259:984–987. 
  11.  Zhang, J., A. Bottaro, S. Li, V. Stewart, and F.W. Alt. 1993. A selec-
tive defect in IgG2b switching as a result of targeted mutation of the I 
gamma 2b promoter and exon. EMBO J. 12:3529–3537.
  12.  Seidl, K.J., A. Bottaro, A. Vo, J. Zhang, L. Davidson, and F.W. Alt. 
1998. An expressed neo(r) cassette provides required functions of the 
1gamma2b exon for class switching. Int. Immunol. 10:1683–1692. 
  13.  Qiu, G., G.R. Harriman, and J. Stavnezer. 1999. Ialpha exon-replace-
ment mice synthesize a spliced HPRT-C(alpha) transcript which may 
explain their ability to switch to IgA. Inhibition of switching to IgG in 
these mice. Int. Immunol. 11:37–46. 
  14.  Manis,  J.P.,  N.  van  der  Stoep,  M.  Tian,  R.  Ferrini,  L.  Davidson,   
A. Bottaro, and F.W. Alt. 1998. Class switching in B cells lacking 3  
immunoglobulin heavy chain enhancers. J. Exp. Med. 188:1421–1431. 
  15.  Pinaud, E., A.A. Khamlichi, C. Le Morvan, M. Drouet, V. Nalesso, 
M. Le Bert, and M. Cogne. 2001. Localization of the 3 IgH locus ele-
ments that effect long-distance regulation of class switch recombination. 
Immunity. 15:187–199. 
  16.  Wuerffel, R., L. Wang, F. Grigera, J. Manis, E. Selsing, T. Perlot, 
F.W. Alt, M. Cogne, E. Pinaud, and A.L. Kenter. 2007. S-S synapsis 
during class switch recombination is promoted by distantly located 
transcriptional elements and activation-induced deaminase. Immunity. 
27:711–722. 
  17. Nambu, Y., M. Sugai, H. Gonda, C.G. Lee, T. Katakai, Y. Agata, 
Y. Yokota, and A. Shimizu. 2003. Transcription-coupled events asso-
ciating with immunoglobulin switch region chromatin. Science. 302: 
2137–2140. 
  18. Wang, L., N. Whang, R. Wuerffel, and A.L. Kenter. 2006. AID-
  dependent histone acetylation is detected in immunoglobulin S regions. 
J. Exp. Med. 203:215–226. 
  19.  Wang, J.H., A. Nichogiannopoulou, L. Wu, L. Sun, A.H. Sharpe, M. 
Bigby, and K. Georgopoulos. 1996. Selective defects in the develop-
ment of the fetal and adult lymphoid system in mice with an Ikaros null 
mutation. Immunity. 5:537–549. 
  20.  Reynaud, D., I.A. Demarco, K.L. Reddy, H. Schjerven, E. Bertolino, 
Z. Chen, S.T. Smale, S. Winandy, and H. Singh. 2008. Regulation of 
B cell fate commitment and immunoglobulin heavy-chain gene rear-
rangements by Ikaros. Nat. Immunol. 9:927–936.
  21.  Kirstetter, P., M. Thomas, A. Dierich, P. Kastner, and S. Chan. 2002. 
Ikaros is critical for B cell differentiation and function. Eur. J. Immunol. 
32:720–730. 
  22.  Thompson, E.C., B.S. Cobb, P. Sabbattini, S. Meixlsperger, V. Parelho,   
D. Liberg, B. Taylor, N. Dillon, K. Georgopoulos, H. Jumaa, et al.   
2007.  Ikaros  DNA-binding  proteins  as  integral  components  of  B 
cell developmental-stage-specific regulatory circuits. Immunity. 26: 
335–344.
  23.  Liu, Z., P. Widlak, Y. Zou, F. Xiao, M. Oh, S. Li, M.Y. Chang, J.W. 
Shay, and W.T. Garrard. 2006. A recombination silencer that specifies 
heterochromatin positioning and ikaros association in the immunoglob-
ulin kappa locus. Immunity. 24:405–415. 
Ligation products were analyzed by qPCR in duplicate or triplicate using 
200 ng DNA. Absolute quantities were calculated using a template consisting 
of equimolar ratios of all possible ligation products. The template was constructed 
as previously described (60) with PCR fragments from the Igh and Gapd loci and 
diluted in genomic DNA. qPCR specificity was confirmed with negative con-
trols (without fixation, digestion, or ligation), melting point analysis, digestion of 
PCR products with HindIII, and migration of PCR and digestion products on 
2% agarose gels (Fig. S9 B). Relative cross-linking frequency was calculated as 
follows: cross-linking frequency = ([HS1,2  fragment X]/[HS4 0.5 kb load-
ing control])/([Gapd 3  Gapd 5]/[HS4 0.5 kb]).
EMSA. Nuclear extracts (NEs) and EMSAs were prepared as previously de-
scribed (61). 2.5 µg NE from Cos cells transfected with mock cDNA or cDNA 
coding for Ik1 proteins or 4 µg NE from CSR-induced B cells was used.
Online supplemental material. Table S1 summarizes raw data from SC-
RT-PCR experiments. Table S2 lists oligonucleotides. Fig. S1 shows statis-
tical analysis of WT and IkL/L CSR frequencies after LPS, LPS + IL-4, LPS + 
IFN-, and LPS + IL-5 + TGF- stimulation. Fig. S2 quantifies Ig isotype 
production by WT and IkL/L B cells using ELISA. Fig. S3 analyzes WT   
and IkL/L CSR frequency as a function of proliferation. Fig. S4 examines 
CSR in whole and bona fide unswitched WT and IkL/L B cells. Fig. S5   
shows the effect of retroviral expression of dominant-negative Ikaros on 
CSR in WT cells, and full-length and exon 2–deleted Ikaros isoforms on 
CSR in IkL/L B cells. Fig. S6 shows RT-qPCR analysis of aicda expression in 
stimulated WT and IkL/L cells. Fig. S7 shows SC-RT-PCR analysis of aicda,   
3 GLT, and 2b GLT expression in freshly isolated IgM+CD43 B cells 
and CD4+CD3+ T cells. Fig. S8 shows RT-qPCR analysis of , 3, 2b,   
and 2a GLT expression in WT and IkL/L B cells after 48 h with LPS and 
one or three divisions. Fig. S9 shows digestion efficiency and PCR specific-
ity controls for 3C experiments. Fig. S10 shows ChIP-qPCR and DC-
ChIP-qPCR for Mi-2, Sin3a, HDAC1, and HDAC2 at the Igh locus in   
WT and IkL/L cells. Fig. S11 shows the effect of Mi-2 shRNA knockdown   
on CSR in WT B cells. Online supplemental material is available at http://
www.jem.org/cgi/content/full/jem.20082311/DC1.
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